IQI
EOLS icon

Integrated Quantitative Investments’s Evolus EOLS Stock Holding History

Integrated Quantitative Investments’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,972
Closed -$279K – 439
2025
Q4 		$279K Buy
+41,972
New +$284K 0.06% 342

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Quantitative Investments's EOLS Position: Q1 2026 in Review

Integrated Quantitative Investments sold out of Evolus (EOLS) in Q1 2026, closing a stake of 41,972 shares — an estimated $279K sold.

Integrated Quantitative Investments first reported a position in EOLS in Q4 2025 and held it in 1 quarter. The position peaked at $279K in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • Integrated Quantitative Investments reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 41,972 Evolus shares in Q1 2026, an estimated $279K.
  • Integrated Quantitative Investments first reported a position in Evolus in Q4 2025 and held it in 1 quarter.
  • Integrated Quantitative Investments's Evolus position peaked at $279K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.